Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
2.
J Cardiothorac Vasc Anesth ; 26(3): 433-8, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22265337

RESUMEN

OBJECTIVES: The aim of this study was to describe anesthetic management and perioperative complications in patients undergoing pulmonary vein isolation for the treatment of atrial fibrillation under general anesthesia using high-frequency jet ventilation. The authors also identified variables associated with longer ablation times in this patient cohort. DESIGN: A retrospective observational study. SETTING: The electrophysiology laboratory in a major university hospital. PARTICIPANTS: One hundred eighty-eight consecutive patients undergoing pulmonary vein isolation under general anesthesia with high-frequency jet ventilation. INTERVENTIONS: High-frequency jet ventilation was used as the primary mode of ventilation under general anesthesia. MEASUREMENTS AND MAIN RESULTS: High-frequency jet ventilation was performed successfully throughout the ablation procedure in 175 cases of the study cohort. The remaining 13 patients had to be converted to conventional positive-pressure ventilation because of high PaCO(2) or low PaO(2) on arterial blood gas measurements. Variables associated with a shorter ablation time included a higher ejection fraction (p = 0.04) and case volume performed by each electrophysiologist in the study group (p = 0.001). CONCLUSIONS: High-frequency jet ventilation is generally a safe technique that can be used in catheter ablation treatment under general anesthesia.


Asunto(s)
Anestesia General/métodos , Fibrilación Atrial/cirugía , Ablación por Catéter/métodos , Ventilación con Chorro de Alta Frecuencia/métodos , Venas Pulmonares/cirugía , Anciano , Índice de Masa Corporal , Dióxido de Carbono/sangre , Femenino , Ventilación con Chorro de Alta Frecuencia/efectos adversos , Humanos , Periodo Intraoperatorio , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Presión Parcial , Estudios Retrospectivos
3.
J Histochem Cytochem ; 56(12): 1049-63, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18574253

RESUMEN

Parkinson's disease (PD) affects >1 million Americans and is marked by the loss of dopaminergic neurons in the substantia nigra. PD has been linked to two causative factors: genetic risks (hereditary PD) and environmental toxins (idiopathic PD). In recent years, considerable effort has been devoted to the development of a Drosophila model of human PD that might be useful for examining the cellular mechanisms of PD pathology by genetic screening. In 2000, Feany and Bender reported a Drosophila model of PD in which transgenic flies expressing human mutant alpha-synuclein exhibited shortened life spans, dopaminergic losses, Parkinsonian behaviors, and Lewy bodies in surviving dopaminergic neurons. Since then, a number of studies have been published that validate the model or build on it; conversely, a number report an inability to replicate the results and suggest that most protocols for dopaminergic histology underreport the actual numbers of dopaminergic neurons in the insect brain. Here we report the optimization of dopaminergic histology in Drosophila and identification of new dopaminergic neurons, show the remarkable dendritic complexity of these neurons, and provide an updated count of these neurons in adult brains. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials.


Asunto(s)
Dopamina/metabolismo , Drosophila melanogaster/metabolismo , Técnicas de Preparación Histocitológica/métodos , Neuronas/metabolismo , Animales , Encéfalo/citología , Encéfalo/metabolismo , Recuento de Células , Dendritas/ultraestructura , Drosophila melanogaster/citología , Fijadores , Inmunohistoquímica , Neuronas/citología , Coloración y Etiquetado , Adhesión del Tejido , Fijación del Tejido
4.
Anesthesiol Res Pract ; 2013: 149892, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24069030

RESUMEN

Background. Perioperative management of cocaine-abusing patients scheduled for elective surgery varies widely based on individual anecdotes and personal experience. Methods. Chiefs of the anesthesia departments in the Veterans Affairs (VA) health system were surveyed to estimate how often they encounter surgical patients with cocaine use. Respondents were asked about their screening criteria, timing of screening, action resulting from positive screening, and if they have a formal policy for management of these patients. Interest in the development of VA guidelines for the perioperative management of patients with a history of cocaine use was also queried. Results. 172 VA anesthesia departments' chiefs were surveyed. Response rate was 62%. Over half of the facilities see cocaine-abusing patients at least once a week (52%). Two thirds of respondents canceled or delayed patients with a positive screen regardless of clinical symptoms. Only eleven facilities (10.6%) have a formal policy. The majority of facilities (80%) thought that having formal guidelines for perioperative management of cocaine-abusing patients would be helpful to some extent. Results. 172 VA anesthesia departments' chiefs were surveyed. Response rate was 62%. Over half of the facilities see cocaine-abusing patients at least once a week (52%). Two thirds of respondents canceled or delayed patients with a positive screen regardless of clinical symptoms. Only eleven facilities (10.6%) have a formal policy. The majority of facilities (80%) thought that having formal guidelines for perioperative management of cocaine-abusing patients would be helpful to some extent. Conclusions. There is a general consensus that formal guidelines would be helpful. Further studies are needed to help formulate evidence-based guidelines for managing patients screening positive for cocaine prior to elective surgery.

5.
J Neurosurg ; 114(3): 587-94, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20887095

RESUMEN

OBJECT: As the population ages, the incidence of glioblastoma multiforme (GBM) among older patients (age > 65 years) will increase. Older patients, unlike their younger counterparts, are not often offered aggressive surgery because of their age, comorbidities, and potential inability to tolerate surgery. The goal of this study was to identify preoperative factors associated with decreased survival for older patients who underwent resection of a GBM. The identification of these factors may provide insight into which patients would benefit most from aggressive surgery. METHODS: All patients older than 65 years who underwent nonbiopsy resection of an intracranial GBM at a single institution between 1997 and 2007 were retrospectively reviewed. Factors associated with overall survival were assessed using multivariate proportional hazards regression analysis after controlling for peri- and postoperative factors known to be associated with outcome (extent of resection, carmustine wafer implantation, temozolomide chemotherapy, and radiation therapy). Variables with p < 0.05 were considered statistically significant. RESULTS: A total of 129 patients with an average age of 73 ± 5 years met the inclusion/exclusion criteria. At last follow-up, all 129 patients had died, with a median survival of 7.9 months. The preoperative factors that were independently associated with decreased survival were Karnofsky Performance Scale (KPS) score less than 80 (p = 0.001), chronic obstructive pulmonary disease (p = 0.01), motor deficit (p = 0.01), language deficit (p = 0.005), cognitive deficit (p = 0.02), and tumor size larger than 4 cm (p = 0.002). Patients with 0-1 (Group 1), 2-3 (Group 2), and 4-6 (Group 3) of these factors had statistically different survival times, where the median survival was 9.2, 5.5, and 4.4 months, respectively. In log-rank analysis, the median survival for Group 1 was significantly longer than that for Group 2 (p = 0.004) and Group 3 (p < 0.0001), while Group 2 had longer survival than Group 3 (p = 0.02). CONCLUSIONS: Older patients with an increasing number of these factors may not benefit as much from aggressive surgery as patients with fewer factors. This may provide insight into identifying which patients older than 65 years of age may benefit from aggressive surgery.


Asunto(s)
Neoplasias Encefálicas/cirugía , Glioblastoma/cirugía , Procedimientos Neuroquirúrgicos , Anciano , Anciano de 80 o más Años , Envejecimiento/fisiología , Análisis de Varianza , Antineoplásicos Alquilantes/uso terapéutico , Neoplasias Encefálicas/terapia , Carmustina/uso terapéutico , Terapia Combinada , Femenino , Glioblastoma/terapia , Humanos , Estimación de Kaplan-Meier , Estado de Ejecución de Karnofsky , Imagen por Resonancia Magnética , Masculino , Periodo Perioperatorio , Periodo Posoperatorio , Estudios Retrospectivos , Análisis de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA